New Launch16 Oct 2025, 08:15 pm
Novelix Pharmaceuticals Limited Collaborates with GMBU e.V., Germany for Large-Scale Production of Astaxanthin
AI Summary
Novelix Pharmaceuticals Limited has entered into a Technology Transfer agreement with GMBU e.V., Germany, for the transfer of technological know-how related to the production and scale-up of Astaxanthin at the company’s research facilities in Hyderabad, India. The collaboration aims to bring Astaxanthin to market at a commercial scale for global supply. Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program. The company will also establish a GMP-certified production facility at its Techno Park site in Hyderabad to manufacture Astaxanthin in bulk, targeting key markets across Europe, North America, and India.
Key Highlights
- Novelix Pharmaceuticals Limited has signed a Technology Transfer agreement with GMBU e.V., Germany for the production and scale-up of Astaxanthin.
- The collaboration aims to bring Astaxanthin to market at a commercial scale for global supply.
- Novelix will provide financial and infrastructural support for the technology transfer and scale-up program.
- A GMP-certified production facility will be established at Novelix’s Techno Park site in Hyderabad to manufacture Astaxanthin in bulk.
- The target markets for the Astaxanthin are Europe, North America, and India.